24-hour anti-ischaemic action with once daily nifedipine : experience obtained with a fatty-alcohol matrix tablet in patients with coronary artery disease

The ability of a fatty-alcohol matrix, slow-release tablet of nifedipine 60 mg to maintain a 24-hour antiischaemic action in the fixed dose of 60 mg once daily has been investigated in a randomised, placebo-controlled, double-blind trial.